Select a community
Devic's
Find out more about the PatientsLikeMe
Devic's Community
Home > Community Treatment Reports > Oxybutynin Treatment Report
What is Oxybutynin?

Oxybutynin is anti-cholinergic drug used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. It is available in oral form, extended release and as a transdermal patch.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Bladder problems 3 0
Other 2 0
Urinary urgency 1 0
General health 1 0
Neurogenic Bladder 1 0
Freedom and quality of life to leave the house in confidenceand enjoy my social life again! 1 0

Mouse over the table for more information

Dosages

  5 mg daily 10 mg daily 15 mg daily 20 mg daily
  2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Oxybutynin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 67% Side effects too severe: 67%
Did not seem to work
1 33% Did not seem to work: 33%
Doctor's advice
1 33% Doctor's advice: 33%
Course of treatment ended
1 33% Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Oxybutynin

Currently Taking Oxybutynin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
3

Stopped Taking Oxybutynin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.